Immunoglobulin light chain (AL) amyloidosis is a rare and potentially
life‐threatening disorder characterized by the deposition of
misfolded, toxic immunoglobulin light chains in organs and tissues,
typically produced by a plasma cell (PC) clone.
1
The deposition of
amyloidogenic light chains disrupts tissue structure, leading to organ
dysfunction with a wide range of symptoms and clinical
manifestations